People, industry & policy / News
Gary Brecka brought his longevity tour to New York
The November 15 program, the charity it supported, and what the organizer announced.
Read the storyPeople, industry & policy / News
The November 15 program, the charity it supported, and what the organizer announced.
Read the storyCheck the evidence and cost of what you already take.
Explore graded options for your goals and experience.
Compare your selections with documented expert routines.
The evidence library
172 ingredients and 21 protocols, with evidence grades, costs, sources and limitations.
Aging biology, genomics and emerging treatments.
What anti-aging treatments can changeWhat is NAD, and what do NMN and NR actually do?Psilocybin and Longevity: What the Mouse Study Actually FoundSupplements, devices, testing and experiments.
The Best Longevity Newsletters and Publications, Sorted by Evidence StandardCollagen for joint pain: what the trials showGlucosamine for knee pain: why the evidence differsDiets, metabolic health and the evidence behind food claims.
What Does the Evidence Say About Omega-3 for Longevity?What Barbara O'Neill Teaches: The Evidence, Item by ItemExercise, sleep, cognition and recovery.
Super Veggie and Nutty Pudding, Recosted: The Lunch Is 510 Calories, Not the Circulating 379, and the Brazil Nut Contradicts His Own ArchiveIndoor Air: Houseplants Would Need 10 to 1,000 Per Square Metre to Match the Air Exchange a Room Already GetsRed Light Therapy: Hair Growth Has Eleven Sham-Controlled Trials Behind It, and the Daily Panel Routine Has NoneSkin, reproductive health, fertility preservation and screening.
Cinnamon for Blood Sugar: The Form With the Trials Is the Form With the LimitThe Executive Screening Stack, Graded: What to Buy, What to SkipThe people, companies and policies shaping longevity.
Creatine for Women: Five Grams With Training Is Where the Trials Find the BenefitMelatonin for Sleep: Seven Minutes Faster Asleep, and a Shelf Dose Ten Times the Studied OneGary Brecka brought his longevity tour to New YorkLatest source briefing · Week of Nov 16, 2026
policy · Nov 13, 2026
The HHS comment window on the peptide policy closed Friday, November 13. AgelessRx and Noom's OpenRx both moved this week to offer or review the policy's peptides through clinician-led channels, while every peptide named in the policy still stands at a D grade in our library and none is FDA-approved.
Read the source ↗safety · Nov 12, 2026
Health Canada's November 12 advisory reports lab testing found bacteria (Sphingomonas species) in an injectable seized from Sage & Summit Wellness Co.; the store agreed to stop selling. A product and seizure specific finding that changes no grade.
Read the source ↗newsletter · Nov 19, 2026
Issue 4 of the Longevity Lab Report newsletter, locked Wednesday, covers the peptide docket aftermath, the Health Canada advisory, retatrutide's Phase 3 results in the NEJM, and the FDA's NAC proposed rule. It sends Thursday, November 19 at 9:00 AM ET.
Read the source ↗Our reporting links to its sources. Library grades follow a published method, and sponsors do not influence them.
Editorial policy ↗How we grade ↗